Lipopolysaccharide-induced increase of prostaglandin E2 is mediated by inducible nitric oxide synthase activation of the constitutive cyclooxygenase and induction of membrane-associated prostaglandin E synthase

Journal of Immunology

Volumn 167, Issue 7, 2001, Pages 3962-3971

  Devaux, Y ^a   Seguin, C ^a   Grosjean, S ^a   De Talance N ^a   Camaeti, V ^a   Burlet, A ^a   Zannad, F ^a   Meistelman, C ^a   Mertes, P M ^a   Longrois, D ^a  

^a CHU NANCY BRABOIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 [5 (4 CHLOROPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; AMINOGUANIDINE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; KETOPROFEN; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; SYNTHETASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG CONTRAINDICATION; DRUG EFFECT; IMMUNE RESPONSE; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0035478595     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.7.3962     Document Type: Article

References (62)

1. Inducible nitric oxide synthase: What difference does it make?
2. Cylokine regulation of nitric oxide production
3. Myocardial contractile dysfunction in the systemic inflammatory response syn- drome: Role of a cylokine-inducible nitric oxide synthase in cardiac myocytes
4. Nitric oxide synthesis, serves to reduce hepatic damage during acute murine endotoxemia
5. Effects of a nitric oxide synthase inhibitor in humans with septic shock
6. Role of endogenous nitric oxide in septic shock
7. Inducible nitric oxide synthase and tumor necrosis factor in animal models of myocardial necrosis induced by coronary artery ligation or isoproterenol injection
8. Regulalory functions of phospholipase A2
9. Cycloxygenases: Structural, cellular, and molecular biology
10. Cyclooxygenases 1 and 2
11. Cyclooxygenase in biology and disease
12. 2 biosynthesis
13. 2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cycloxygenase-2
14. Role of inducible nitric oxide synthase and cyclooxygenase-2 in eodotoxin-induced cerebral hyperemia
15. The L-arginine-nitric oxide pathway
16. Effects of nitric oxide and nitric oxide-derived species on prostaglandin endoperoxide synthase and prostaglandin biosynthesis
17. Regulation of biosynthesis of nitric oxide
18. Retinoic acid and host-pathogen interactions: Effects on the inducible nitric oxide synthase in vivo
19. Induction of diaphragmatic nitric oxide synthase after endotoxin adminislralion in rats: Role on diaphragmatic contractile dysfunction
20. Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: Pharmacological evaluation of nitric oxide synthase inhibitors
21. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms
22. +-ketoprofen in vivo
23. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxy-genase-2 inhibitors: Identification of 4-[5 (4-methylphenyl)-3-(trifluoromethyl)-lH-pyrazol-l-yl]benzenesulfonamide (SC-58635, celecoxib)
24. 20 Years' experience with ketoprofen
25. A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors
26. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic
27. Selective inhibition of cyclooxygenase 2 spares renal function and prostaglandin synthesis in cirrhotic rats with ascites
28. 4 accelerate resolution of allergic edema in Angiostrongylus costaricensis-infected rats: Relationship with concurrent eosinophilia
29. Aminoguanidine, a novel inhibitor of nitric oxide formulation, prevents diabetic vascular dysfunction
30. Amino-guanidine selectively inhibits inducible nitric oxide synthase
31. Inhibitors of nitric oxide synthases
32. Diferential regulation of cyclo-oxygenase-1 and cyclo-oxygenase-2 gene expression by lipopolysaccharide treatment in vivo in the rat
33. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity
34. Prostaglandin synthase 2
35. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2
36. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: Implications for gastrointestinal toxicity
37. Prostaglandin synthase 1 gene disruption in mice reduces arachidoniv acid-induced inflammation and indomethacin-induced gastric ulceration
38. Pharmacological analysis of cyclooxygenase-1 in inflammation
39. Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation
40. Nitric oxide activates cyclooxygenase enzymes
41. Endogenous nitric oxide enhances prostaglandin production in a model of renal inflammation
42. Regulation of prostaglandin production by nitric oxide; an in vivo analysis
43. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase
44. Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells
45. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis
46. Regulation of the expression of cyclooxygenase-2 by nitric oxide in rat peritoneal macrophages
47. Co-induction of nitric oxide synthase and cyclo-oxygenase: Interactions between nitric oxide and prostanoids
48. Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin-6 by rat Kupffer cells
49. Interferon-γ and nitric oxide down-regulate lipopolysaccharide-induced prostanoid production in cultured rat microglial cells by inhibiting cyclooxygenase-2 expression
50. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation
51. Nitric oxide: A prostaglandin H synthase 1 and 2 reducing cosubstrate that does not stimulate cyclooxygenase activity or prostaglandin H synthase expression in murine macrophages
52. Interactions between inducible isoforms of nitric oxide synthase and cyclo-oxygenase in vivo: Investigations using the selective inhibitors, 1400W and celecoxib
53. Nitric oxide synthase/COX cross-talk: Nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production
54. Modulation by nitric oxide of prostaglandin biosynthesis in the rat
55. Diffusion of peroxynitrite into the human platelet inhibits cyclooxygenase via nitration of tyrosine residues
56. 4
57. 2 isomerase activity by PDGF: Involvement of nitric oxide
58. Factors regulating the biosynthesis of various prostaglandins
59. Regulation of nitric oxide production by stimulated rat Kupffer cells
60. Prostanoids inhibit Kupffer cell nitric oxide synthesis
61. Modulation of the induction of nitric oxide synthase by eicosanoids, in the murine macrophage cell line J774
62. Nitric oxide production from macrophages is regulated by arachidonic acid metabolites